| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.9M | +44.3% |
| R&D Expense | $82.2M | +57.4% |
| SG&A Expense | $38.0M | +56.3% |
| Operating Income | -$106.4M | -58.9% |
| Pre-tax Income | -$99.4M | -49.2% |
| Income Tax | $70K | -78.2% |
| Net Income | -$99.4M | -48.6% |
| EPS (Basic) | -$1.64 | +22.3% |
| EPS (Diluted) | -$1.64 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.3M | -75.7% |
| Accounts Receivable | $202K | -82.5% |
| Current Assets | $260.2M | -33.5% |
| Total Assets | $373.8M | -15.5% |
| Current Liabilities | $28.1M | +8.9% |
| Total Liabilities | $72.9M | +33.7% |
| Stockholders' Equity | $300.9M | -22.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$91.0M | -179.7% |
| Capital Expenditures | $6.5M | +204.3% |
| Investing Cash Flow | -$93.2M | +47.1% |
| Financing Cash Flow | $2.1M | -99.5% |
| Free Cash Flow | -$97.4M | -181.2% |
| +22.3% |